🚀 ProPicks AI Hits +34.9% Return!Read Now

Balchem shareholders approve board nominees, auditor

EditorNatashya Angelica
Published 2024-06-24, 04:34 p/m
BCPC
-

Balchem (NASDAQ:BCPC) Corporation (NASDAQ:BCPC), a Maryland-based chemical products company, announced the results of its Annual Meeting of Shareholders, which took place on June 20, 2024. Shareholders voted on several key issues, including the election of directors and the appointment of the company’s independent auditor.

The company's shareholders elected four Class 2 director nominees to its Board of Directors, who will serve until the Annual Meeting of Shareholders in 2027 or until their successors are elected and qualified. Daniel Knutson received 27,420,722 votes for, 534,637 against, and 11,582 abstentions.

Joyce Lee received 23,968,891 votes for, 3,987,153 against, and 10,897 abstentions. Olivier Rigaud got 24,601,193 votes for, 3,350,287 against, and 15,461 abstentions. Monica Vicente was elected with 27,844,683 votes for, 111,268 against, and 10,990 abstentions. There were also 1,555,476 broker non-votes for each nominee.

In addition to the director elections, shareholders ratified the appointment of RSM US LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2024, with 28,981,040 votes for, 536,045 against, and 5,332 abstentions.

Furthermore, the advisory vote on the compensation of the company’s named executive officers passed with 27,117,930 votes for, 813,592 against, and 35,419 abstentions, alongside 1,555,476 broker non-votes.

The voting results affirm the shareholders' support for the company's current leadership and financial oversight practices. Balchem, known for its specialty chemicals and ingredients, has a presence in various industrial applications and services.

This information is based on a press release statement filed with the Securities and Exchange Commission on June 24, 2024.

In other recent news, Balchem Corporation has reported a strong Q1 performance for 2024, with record sales and adjusted EBITDA. The company's consolidated revenues reached $240 million, indicating a 3.1% increase from the previous year.

This growth was primarily driven by a favorable product mix and robust performance in the Human Nutrition & Health segment. Despite challenging market conditions, particularly in the Animal Nutrition & Health segment, Balchem's net income rose by 27.6%.

In addition to these financial highlights, Balchem has also formed a partnership with the New York Jets to promote the VitaCholine brand. This is part of the company's ongoing marketing initiatives aimed at increasing product awareness and sales. Despite facing challenges in the Animal Nutrition & Health segment, Balchem remains optimistic about its long-term growth prospects.

Moreover, Balchem is taking measures to improve market conditions in Europe, including considering anti-dumping tariffs. These recent developments underscore Balchem's proactive approach to navigating market dynamics and its commitment to driving growth across all segments.

InvestingPro Insights

As Balchem Corporation (NASDAQ:BCPC) shareholders show confidence in the company's leadership, a look at real-time data from InvestingPro provides additional context to their decision. With a market capitalization of $4.92 billion, the company's valuation metrics indicate a substantial presence in the specialty chemicals sector.

Despite a slight revenue decline over the last twelve months as of Q1 2024, Balchem's gross profit margin remains robust at 33.39%, underscoring its ability to maintain profitability. The company's P/E ratio stands at a relatively high 42.69, which may reflect investor expectations for future earnings growth.

Among the InvestingPro Tips, it is notable that Balchem has raised its dividend for 14 consecutive years, demonstrating a commitment to shareholder returns. Moreover, the company has maintained dividend payments for an impressive 38 consecutive years. For investors seeking stability, Balchem's stock generally trades with low price volatility.

With more insights available, readers can explore additional InvestingPro Tips for Balchem by visiting https://www.investing.com/pro/BCPC. To delve deeper into these metrics and gain further insights, use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription. With 13 more InvestingPro Tips listed, there's a wealth of information awaiting those looking to make informed investment decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.